Brief: Suven Life Sciences Approves Rights Issue Of Shares In 1:2 Ratio
12/10/2022 12:35
Oct 12 (Reuters) - Suven Life Sciences Ltd SUVP.NS :
* APPROVED RIGHTS ISSUE OF SHARES IN 1:2 RATIO
Source text for Eikon: ID:nBSE4SG0HZ
Further company coverage: SUVP.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Suven Life Sciences
See all newsBrief: Suven Life Sciences Completes Phase-1 Study Of SUVN-I6107, Advances To Phase-2
Brief: Suven Life Sciences Reports Positive DSMB Safety Review For Phase-3 Masupirdine Study
Brief: Suven Life Sciences Records 100% Patient Enrolment Milestone In Phase-2B Clinical Trial Of Ropanicant
Brief: Suven Life Sciences Says First Patient Randomized In Phase-2B Clinical Trial Of Ropanicant
Brief: Suven Life Sciences March-Quarter Consol Net Loss 439.4 Million Rupees